Valeant Pharmaceuticals reported $10.39B in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Ani Pharmaceuticals ANIP:US USD 1000 0
Aurora Cannabis Inc ACB:CN CAD 6.76B 9.99M
Biogen BIIB:US USD 100K 0
Canopy Growth Corp WEED:CN CAD 7.82B 216.52M
Catalent CTLT:US USD 2M 0
Corcept Therapeutics CORT:US USD 130K 2K
Danaher DHR:US USD 9M 0
Drreddys Laboratories RDY:US INR 833M 1000K
Endo International Ordinary Shares ENDP:US USD 63K 3K
Horizon Pharma HZNP:US USD 23K 0
Lannett LCI:US USD 43K 0
Nektar Therapeutics NKTR:US USD 19K 0
Pacira Pharmaceuticals PCRX:US USD 46K 0
Perrigo Ordinary Shares PRGO:US USD 6.96B 27.4M
Phibro Animal Health PAHC:US USD 4K 0
Prestige Brands PBH:US USD 548K 1000
Revance Therapeutics RVNC:US USD 82K 9K
Supernus Pharmaceuticals SUPN:US USD 54K 1000
Valeant Pharmaceuticals VRX:CN USD 10.39B 7M
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Zoetis ZTS:US USD 5M 0